Investment
Features
FeesSafety
Academy
More
Pluang+

Compare NetFlix Inc (NFLX) vs Viatris Inc (VTRS) Price & Performance

NetFlix IncTrade
Viatris IncTrade

Price performance (Past 24H)

Key statistics

NetFlix Inc vs Viatris Inc — how do they compare? NetFlix Inc trades at $76.13 (market cap $316.58B), while Viatris Inc trades at $16.5 (market cap $18.95B). The key difference: NetFlix Inc is far larger — about 16.7× Viatris Inc's market cap, and Viatris Inc pays a 2.91% dividend while NetFlix Inc pays none. Which is the better fit depends on your goals.

NFLXVTRS
Market Cap
$316.58B$18.95B
Sector
Consumer CyclicalHealth
52-Week High
$124.77$17.86
52-Week Low
$67.60$9.49
Enterprise Value
$321.77B$31.07B
Dividend Yield
2.91%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

NetFlix Inc

Netflix (NFLX) is trading at $76.03, down 2.84% on the day, amid a bearish technical signal and recent price weakness. The stock is near its 52-week low, with support at $76 and resistance at $78. Fundamentally, the company shows strong revenue growth, with 2025 revenue at $45.18 billion and net income of $10.98 billion, and has beaten EPS estimates for the last three quarters. Analyst sentiment remains largely positive with a consensus buy rating and price target of $88.95, though recent news highlights concerns over the stock's performance streak.

The outlook for NFLX is mixed; strong fundamentals and analyst optimism suggest potential upside, but technical bearishness and competitive pressures pose risks. Investors should weigh robust profitability and ad-tier expansion against market volatility and execution challenges in the streaming sector.

Viatris Inc

Viatris (VTRS) trades at $16.61, down 1.6% on the day, with a bullish technical signal but mixed moving averages. The company reported Q2 2026 EPS of $0.69, beating estimates, and revenue growth of 5% year-over-year. Despite negative net income margins, strong cash flow generation supports dividends and buybacks. Recent news highlights pipeline progress and a higher 2026 outlook.

Outlook: Viatris shows operational strength with consistent earnings beats and cash flow, but high P/E and negative profitability pose risks. Investment opportunity lies in deleveraging and pipeline advancements, while headwinds include generic drug pricing pressure and regulatory uncertainty. Analyst sentiment is mixed with a hold-heavy consensus.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About NetFlix Inc

Netflix Inc. is an Internet subscription service for watching television shows and movies. Subscribers can instantly watch unlimited television shows and movies streamed over the Internet to their televisions, computers, and mobile devices and in the United States, subscribers can receive standard definition DVDs and Blu-ray Discs delivered to their homes.

Read more on NFLX

About Viatris Inc

Formed by the combination of Mylan and Pfizer's Upjohn business in 2020, Viatris is one of the world's largest generic drug manufacturers, with a substantial off-patent branded drug portfolio. Its portfolio consists of more than 1,400 molecules with penetration across most of the developed world and in select emerging markets. The company's branded drug portfolio consists of off-patent blockbuster drugs that continue to generate strong sales, including Lipitor, Norvasc, Lyrica, Viagra, and EpiPen. While global competition has facilitated the commodification of small-molecule generic drugs, the company has demonstrated an edge over peers in its ability to manufacture complex generics (for example, generic Advair and Copaxone).

Read more on VTRS